, Tracking Stock Market Picks
Enter Symbol:
Mei Pharma Inc (MEIP) [hlAlert]

down 80.33 %

Mei Pharma Inc (MEIP) rated Buy with price target $15 by Stifel

Posted on: Tuesday,  Oct 22, 2013  9:25 AM ET by Stifel

Stifel rated Buy Mei Pharma Inc (NASDAQ: MEIP) on 10/22/2013. Previously Stifel rated Buy Mei Pharma Inc (NASDAQ: MEIP) on 04/15/2013.,
when the stock price was $8.44. Since then, Mei Pharma Inc has lost 80.33% as of 01/15/2016's recent price of $1.66.
If you would have followed the previous Stifel's recommendation on MEIP, you would have lost 80.33% of your investment in 1005 days.

Marshall Edwards, Inc. is a US clinical development oncology company and is majority owned by Novogen Limited. Marshall Edwards, Inc. an Australian biotechnology company specializing in the development of a range of therapeutics across the fields of oncology, cardiovascular disease and inflammatory diseases. It is a pharmaceutical company dedicated to the field of cancer therapy.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/22/2013 9:25 AM Buy
10.57 15.00
as of 12/13/2013
1 Week up  2.41 %
1 Month up  13.36 %
3 Months down  -1.85 %
1 YTD down  -19.77 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/15/2013 8:25 AM Buy
8.44 11.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy